- Details
- Description
-
Packaging Size56t/Bottle
-
Strength240mg
-
CompositonVemurafenib
-
TreatmentSkin cancer (melanoma)
-
FormTablet
-
Quantity Unit240mg*56t/Box
-
ManufacturerLucius Pharmaceuticals (Lao) Co.,Ltd
About Vemurafenib
Vemurafenib is a medication used for the treatment of late-stage melanoma. It is an inhibitor of the B-Raf enzyme.
Malignant Melanoma
Indicated for treatment of unresectable or metastatic melanoma with BRAF-V600E mutation as detected by an FDA-approved test
960 mg (4 x 240 mg tablets) PO q12hr (administer approximately 12 hr apart)
See also Administration
Erdheim-Chester Disease
Indicated for the treatment of Erdheim-Chester Disease (ECD) with BRAF V600 mutation
960 mg (4 x 240 mg tablets) PO q12hr (administer approximately 12 hr apart)
Orphan Designations
Thyroid cancer: Treatment of anaplastic thyroid carcinoma and advanced papillary thyroid cancer whose tumors harbor a BRAF V600 mutation
Non-small cell lung cancer (NSCLC) with BRAF V600E mutation
